Variant report

Variant	nsv900822
Chromosome Location	chr13:89397027-89488821
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:89446778..89447282-chr20:52691355..52691999,2	MCF-7	breast:

Extended variants
information (count: 299 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:299 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs188242040	chr13:89400626-89400627	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs540809090	chr13:89400656-89400657	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs373913778	chr13:89400683-89400684	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs553028782	chr13:89400727-89400728	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs577616462	chr13:89400742-89400743	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs76319990	chr13:89400784-89400785	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs563436376	chr13:89400795-89400796	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs192954683	chr13:89400796-89400797	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs542923295	chr13:89400802-89400803	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs150902363	chr13:89400859-89400860	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs529281217	chr13:89400879-89400880	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs547625296	chr13:89400880-89400881	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs566168551	chr13:89400908-89400909	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs533228649	chr13:89400990-89400991	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs138306251	chr13:89401000-89401001	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs79815427	chr13:89401019-89401020	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs537380998	chr13:89401040-89401041	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs183113351	chr13:89401061-89401062	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs555475002	chr13:89401072-89401073	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs568756908	chr13:89401116-89401117	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs567196989	chr13:89401164-89401165	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs534614377	chr13:89401172-89401173	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs552651441	chr13:89401199-89401200	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs79724633	chr13:89401218-89401219	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs186948466	chr13:89401244-89401245	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs191440237	chr13:89401247-89401248	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs144102427	chr13:89401281-89401282	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs575496427	chr13:89401335-89401336	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs542986462	chr13:89401369-89401370	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs561235340	chr13:89401371-89401372	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs534865896	chr13:89401425-89401426	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs528330190	chr13:89401449-89401450	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs183604985	chr13:89401473-89401474	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs147345438	chr13:89401512-89401513	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs543376954	chr13:89401677-89401678	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs189325603	chr13:89401732-89401733	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs551440592	chr13:89401749-89401750	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs139473675	chr13:89401759-89401760	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs193017552	chr13:89401796-89401797	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs377340007	chr13:89401870-89401871	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs370733254	chr13:89401974-89401975	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs118041284	chr13:89401989-89401990	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs185336990	chr13:89401998-89401999	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs567954716	chr13:89402003-89402004	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs374140042	chr13:89402076-89402077	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs368994126	chr13:89402113-89402114	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs114537305	chr13:89402127-89402128	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs190108543	chr13:89402164-89402165	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs145113211	chr13:89402171-89402172	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs78513321	chr13:89402191-89402192	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Myoepithelioma	18604193	CNVD
Breast cancer	17133270	CNVD
Prostate cancer	18632612	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
abnormal development	18461090	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	21965145	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Cancer	21220470	CNVD
Cancer	21183584	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Mantle cell lymphoma	19690137	CNVD
Rhabdomyosarcoma	17210683	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21364760	CNVD
Mental retardation	17847001	CNVD
Medulloblastoma	19270706	CNVD
Myelofibrosis	22110671	CNVD
coloboma	21285886	CNVD
Breast cancer	22522925	CNVD
Osteosarcoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:24 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:89400600-89401000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr13:89401000-89402400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr13:89401400-89402000	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr13:89401400-89402200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr13:89412400-89413800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr13:89413000-89413400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr13:89413200-89413600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr13:89415800-89416600	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr13:89415800-89416600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr13:89415800-89417200	Enhancers	iPS-15b Cell Line	embryonic stem cell
11	chr13:89416000-89416800	Enhancers	HUES48 Cell Line	embryonic stem cell
12	chr13:89416000-89417200	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr13:89416200-89417000	Enhancers	ES-I3 Cell Line	embryonic stem cell
14	chr13:89416400-89416800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
15	chr13:89416600-89417000	Enhancers	iPS-20b Cell Line	embryonic stem cell
16	chr13:89416600-89417200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
17	chr13:89416800-89417200	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr13:89433800-89434200	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr13:89440600-89440800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr13:89440800-89441400	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr13:89441400-89442400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr13:89442400-89442800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr13:89455000-89455600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr13:89469800-89470200	Enhancers	Dnd41	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links